Varying Doses of Rare-Earth-Metal-Based Neodymium Zirconate Zinc Sulfide Nanocomposite Disrupt Blood and Serum Parameters, as well as Markers of Oxidative Stress in the Selected Organs of Albino Mice
by
, ,
Tafheem Khosa
1,†, 
Mourad Ben Said
2,3,†
,
Zia Ur Rehman
4,
Muhammad Ali
5,
Sania Jamil
1,
Qandeel Fatima
1,
Hafsa Hussain
1,
Rehana Iqbal
1,
Adil Khan
6,* and
Furhan Iqbal
1,*
1
Institute of Zoology, Bahauddin Zakariya University, Multan 60800, Pakistan
2
Higher Institute of Biotechnology of Sidi Thabet, University of Manouba, Manouba 2011, Tunisia
3
Laboratory of Microbiology, National School of Veterinary Medicine of Sidi Thabet, University of Manouba, Manouba 2011, Tunisia
4
Department of Physiology, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan
5
College of Veterinary Sciences, Bahauddin Zakariya University, Bahadur Sub Campus Layyah, Layyah 31200, Pakistan
6
Department of Botany and Zoology, Bacha Khan University, Charsadda 24420, Pakistan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Genes 2022, 13(12), 2262; https://doi.org/10.3390/genes13122262
Submission received: 5 November 2022
/
Revised: 22 November 2022
/
Accepted: 29 November 2022
/
Published: 1 December 2022
(This article belongs to the Section Epigenomics)
Abstract
:Despite extensive industrial use, the biocompatibility of nanocomposites has not been extensively explored. The present study was designed to report the effect of variable doses of a newly synthesized nanocomposite, Neodymium Zirconate Zinc Sulfide, on selective serum and complete blood count parameters and on the oxidative stress markers from the vital organs of albino mice. Albino mice (C57BL/6 strain, 5 weeks old) of both sexes were orally treated for 11 days, either with 10 mg (low dose) or 20 mg/mL saline/kg body weight (high dose) of Neodymium Zirconate Zinc Sulfide nanocomposite. A control group that was not treated with the nanocomposite but with saline solution was also maintained. Data analysis revealed that high-dose nanocomposite-treated male mice had significantly reduced hemoglobin concentration as compared to the control males. Female mice treated with both doses of nanocomposite had higher serum triglyceride levels than controls. High-dose-treated female mice had elevated serum cholesterol concentration compared to their saline-treated controls. Oxidative stress marker analysis from selected organs indicated that concentrations of malonaldehyde (MDA) in the kidney and liver, Superoxide dismutase (SOD) levels in the brain and catalase in the kidney of male mice treated with the nanocomposite were significantly higher than in the control group, whereas SOD in the heart, MDA in the heart and kidney and catalase levels in the kidney were significantly disrupted in female mice compared to their respective controls.
1. Introduction
The IIIB group of the periodic table contains seventeen elements that are known as rare Earth elements (REEs) and they are a topic of active research in the current era, as REEs are part of a large number of clinical and industrial applications [1,2]. On the other hand, this extensive REE use has led to extraordinary deposition of these elements in human and animal bodies as well as in the environment through the food chains and webs [3]. Accumulation of REEs beyond safe limits in animals is known as toxicity in the living systems, disturbing their normal neuronal and reproductive physiology [4].
Neodymium is a REE material that is widely used in industry nowadays and it is considered to be the fourth largest REE in use, with an average usage of around 7300 tons per year [5]. Neodymium is commonly used in the manufacture of audio systems, magnets, hybrid engines, hard drives of laptops and wind turbines; all of these materials are part of our daily lives [6], while Zinc Sulfide is commonly used in optical sensors, photoconductors and in dielectric filters [7]. Despite these nanomaterials having a variety of uses and advantages, their safe limits and toxicity have never been explored and it is the need of the hour to determine the biocompatibility of these nanomaterials before their large-scale commercial use to counter their adverse effects to organisms and their environment [8,9]. Recently, we reported that the oral supplementation of Neodymium Zirconate Zinc Sulfide results in disturbed exploratory behavior and muscle activity of albino mice [7]. This led us to investigate whether applied doses of this nanocomposite affect the blood cell count, selective serum parameters and oxidative stress markers from the vital organs of albino mice in a sex-specific manner.
2. Materials and Methods
2.1. Synthesis of Nanocomposite
Neodymium Zirconate Zinc Sulfide nanocomposite used in the present investigation was previously synthesized in our laboratory via the micro-emulsion method as reported earlier [7].
2.2. Experimental Animals
Albino mice (C57BL/6 strain, 5 weeks old) were used as experimental animals and breeding colony was maintained as described previously [7]. Animals were individually kept in locally manufactured rodent cages during the experiments.
2.3. Experimental Design
Five-week-old mice were divided into three groups. Each group contained equal number of males and females. Group 1 (n = 16) orally received the low dose (10mg/mL saline/kg body weight) and group 2 (n = 16) orally received the high dose (20 mg/mL saline/kg body weight) of Neodymium Zirconate Zinc Sulfide nanocomposite. The doses were applied once per day for eleven consecutive days. Group 3 (n = 16) orally received saline solution for the same duration: the control group.
2.4. Determination of Hematological Parameters
Following the specific dose supplementation, the mice were sacralised under Isoflurane anaesthesia and the blood from each animal was either drawn from the retro-orbital sinus or through the cardiac puncture. A part of blood was preserved in a tube containing EDTA as anticoagulant for the determination of complete blood count parameters by using a complete blood count analyzer (Sysmex, Kobe, Hyogo, Japan) following Akram et al. [10].
2.5. Determination of Serological Parameters
A part of blood was collected from each mouse in an Eppendorf tube (without EDTA) and centrifuged at 14,000 RPM for 15 minutes to separate the serum that was later used for the determination of triglycerides, cholesterol, creatinine, albumin, urea and total protein by using a fully automated biochemistry analyzer (Selectra ProM, Paris, France).
2.6. Determination of Biomarkers of Oxidative Stress in Organs
Following the sacrifice, brain, liver, heart, lungs and kidney were surgically removed from each mouse, rinsed in isotonic saline solution and stored at −20 °C until each organ was analyzed for the selective markers of oxidative stress.
Superoxide dismutase (SOD) concentrations were calculated according to Noureen et al. [11]. Briefly, a 10% (w/v) tissue homogenate was prepared in phosphate buffer (0.05 M, pH 7.8) and centrifuged for 15 minutes at 10,000 RPM. Resultant supernatant (0.5 mL) was mixed with 1 mL of sodium carbonate (50 mM), 0.2 mL of EDTA (0.1 mM) and 0.4 mL of NBT (24 µM) in a test tube and mixed by vortexing. Then, 0.4 mL of Hydroxylamine hydrochloride (1 mM) was added to continue the reaction. A reaction mixture without tissue homogenate was run as negative control. Absorbance of SOD was recorded at 560 nm.
Protocol of Saleem et al. [12] was followed for the estimation of lipid peroxidation in mouse organs. Tissue homogenates were prepared in 0.1 M phosphate buffer of pH (7.0). A reaction mixture was prepared by mixing 0.375% thiobarbituric acid (TBA) and 15% trichloroacetic acid (TCA). Then, 300 µL of tissue homogenate and 2 mL of TCA-TBA mixture were mixed in a test tube and a water bath was used to boil it for 15 minutes followed by cooling in ice-chilled water. Tubes were centrifuged at 13,000 RPM for 10 minutes. A supernatant with pink color was produced, the absorbance of which was recorded at 532 nm.
Protocol of Khadija et al. [13] was applied for catalase estimation. Tissue homogenate (10%) was prepared in 0.01 M phosphate buffer pH (7.0) and centrifuged at 10,000 RPM for 10 minutes. Thus, 0.1 mL of supernatant was mixed with 1.4 mL of reaction mixture that contained 0.4 mL of 2M H2O2 and 1 mL of 0.1M phosphate buffer. The reaction was terminated after one minute by adding 2 mL of dichromate-acetic acid. A boiling water bath was used to heat the mixture for 10 min that resulted in stable green-color solution due to the formation of chromic acetate. Negative control samples having distilled water in place of supernatant were used. The % inhibition was calculated at 570 nm.
2.7. Statistical Analysis
Statistical package Minitab (version 16, State College, PA, USA) was used for data analysis. All data were expressed as mean ± standard error of mean. Significance level was set at p < 0.05. One-way ANOVA followed by two-sample Student’s t-test were applied to compare all the parameters of complete blood count, serum and markers of oxidative stress between low- and high-dose Neodymium Zirconate Zinc Sulfide nanocomposite- and saline-treated mice of both sexes.
3. Results
3.1. Characterization of the Neodymium Zirconate Zinc Sulfide Nanocomposite
X-ray diffraction (XRD) analysis was carried out to confirm the crystal structure and purity of the Pyrochlore and Zinc Sulfide. A scanning electron micrograph (SEM) was used to calculate the particle size of the nanocomposite and the particles were in a range of 14.7–42 nm. The detailed synthesis and characterization of the nanocomposite used in this study are provided elsewhere [7].
3.2. Complete Blood Count Analysis
One-way ANOVA test results indicated that haemoglobin concentration was the only parameter among complete blood count analysis that varied significantly (p = 0.01), when compared between nanocomposite-treated and untreated male albino mice. Male albino mice treated with a high dose of nanocomposite exhibited the least haemoglobin concentrations among all three treatments. One-way ANOVA test results did not reach statistical significance (p > 0.05) for any studied parameters when analyzed for female mice).
Two-sample Student’s t test result indicated that haemoglobin level was the only parameter that was significantly reduced (p = 0.02) in low-dose-treated male mice when compared to the control group. All other parameters were varying non-significantly (p ˃ 0.05) when they were compared between low- or high-dose nanocomposite treatments and nanocomposite-untreated mice of both sexes (Table 1).
3.3. Analysis of Serum Biochemical Parameters
One-way ANOVA results revealed that cholesterol (p = 0.01) and triglyceride (p = 0.04) concentration were significantly different when compared between nanocomposite-treated and untreated female albino mice. Female mice treated with a high dose of nanocomposite showed the highest concentration of cholesterol and triglyceride parameters. ANOVA test results were not significant (p > 0.05) when calculated for male mice.
Results of two sample t test indicated that female mice treated with a low (p = 0.03) as well as high dose of nanocomposite (p = 0.02) had more elevated serum triglyceride levels than the saline-treated group, while female mice treated with a high nanocomposite dose had higher serum cholesterol concentration (p = 0.05) compared to the control group (Table 2).
3.4. Analysis of Biomarkers of Oxidative Stress in Vital Organs
One-way ANOVA results revealed that brain superoxide dismutase (SOD) concentrations (p = 0.05) and kidney catalase concentration (p = 0.03) varied significantly when compared between nanocomposite-treated and untreated male albino mice. Highest SOD and catalase concentrations were observed in high-dose nanocomposite-treated male mice.
Two sample Student’s t-test results indicated that malonaldehyde (MDA) concentrations were significantly elevated in the liver (p = 0.05) and kidney (p = 0.03) of low-dose nanocomposite-treated male albino mice compared to nanocomposite-untreated control mice (Table 3). SOD concentrations were found significantly elevated in the brain (p = 0.05) and catalase in the kidney (p = 0.03) of male albino mice treated with a high dose of nanocomposite when compared to their control groups. All other studied biomarkers of oxidative stress in vital organs of male mice varied non-significantly (p > 0.05) when compared between nanocomposite-treated and untreated animals (Table 3 and Table 4).
One-way ANOVA results showed that catalase concentrations in the kidney (p = 0.01) and heart (p = 0.03) of female albino mice varied significantly when compared between control, low and high dose of nanocomposite-treated groups.
Analysis of two-sample Student’s t-test revealed that SOD concentration in the heart was the only parameter that was significantly elevated in low-dose nanocomposite-treated female mice as compared to their respective control groups (Table 3). For high-dose-treated females, t-test results revealed that MDA concentrations in the heart (p = 0.03) and kidney (p = 0.03) and catalase concentration in the kidney (p = 0.03) were significantly decreased as compared to their respective control groups. All other parameters varied non-significantly (p > 0.05) in all organs of nanocomposite-treated and untreated female mice (Table 3 and Table 4).
4. Discussion
Exposure to rare Earth elements (REEs) is known to induce oxidative stress in living systems, in a manner similar to that induced by other transition elements. REE exposure may lead to growth inhibition, genetic defects and toxicity in vital organs [14,15]. Nanomaterials have the ability to gain entry into living systems through a number of routes: through food, water and inhalation or through dermal penetration [11]. Oral administration of nanomaterials results in their interaction with blood components and they are able to induce cell membrane disturbances. Nanomaterials interact with plasma and their associated proteins, which can lead to various pathophysiological processes [16].
Heavy metals are known to disturb the composition and physiology of the hematological system and environmental exposure to high concentrations of these metals can cause anemia in animals [17]. It was recently reported in a human-based study that with the increasing use of REEs, including Neodymium, their concentration is increasing in e-wastes and reaching the population. Henríquez-Hernández et al. [14] reported higher REE levels in sub-Saharan immigrants and found an inverse correlation between most of these elements and the hemoglobin concentrations of these subjects. In another study, conducted on rabbits, Adu et al. [18] observed a significant decrease in mean corpuscular hemoglobin concentration and mean corpuscular hemoglobin following exposure to variable doses of Cerium oxide in the diet. The studied parameters had an inverse correlation with the applied dose of RRE. During the current investigation, we observed a similar significant decrease in hemoglobin concentrations in male mice after exposure to a low dose of Neodymium containing the nanocomposite (Table 1).
We observed that nanocomposite-treated albino mice exhibited a significant increase in serum triglycerides and cholesterol level (Table 2). There are different trends reported in the literature regarding the effects of REEs on serum biochemical parameters. Similar to our findings, Cheng et al. [19] reported a significant elevation in serum triglycerides in mice that were exposed to lanthanides but, in contrast, Wang et al. [20] documented that chronic oral exposure to variable doses of lanthanum chloride (LaCl3) did not affect the serum triglyceride levels of Wistar rats. Similarly, Shin et al. [21] observed no difference in serum triglyceride levels in male rats that were exposed to variable doses of nano-sized La2O3 for 28 days, as compared to the control group.
Huanga et al. [22] reported that entry of rare Earth ions in the liver results in their accumulation in the liver and, eventually, these ions are transformed into meta-stable hydrogen oxide particles, inducing toxicity.
Nanomaterials are known to induce oxidative stress in living systems by generating reactive oxygen species (ROS), affecting normal gene expression, resulting in a number of disease conditions [23]. In order to counter this ROS-mediated toxicity, cells have an antioxidant system consisting of enzymes and non-enzyme biomarkers of oxidative stress that try to maintain normal cellular functioning [8,24]. In the present study, a significant increase in brain SOD levels was observed in high-dose nanocomposite-treated male albino mice (Table 4). Our results are in agreement with Zhao et al. [25] while exposing mice to lanthanides and reported that Ce3+ and Nd3+ caused oxidative stress and toxicity in the mouse brain. They documented that lanthanides trigger a cascade of reactions, including lipid peroxidation of membranes, decreased antioxidation capacity of cells due to decreased antioxidant enzyme activity, excessive release of nitric oxide, increased glutamic acid and downregulated levels of acetylcholine esterase activities [25].
During the present study, male mice exposed to a high dose of the nanocomposite had a significantly elevated catalase concentration compared to the control group (Table 4). Our results are in line with Zhao et al. [26], as they exposed mice to various lanthanide trichlorides and observed RRE accumulation in the kidney, leading to histopathological changes in the kidney, increased ROS production and lipid, DNA and protein peroxidation and disturbed catalase activities.
Oxidative stress also leads to lipid peroxidation of membranes and estimation of Malonaldehyde (MDA) is a standard indicator of membrane catastrophe [27]. MDA has a high affinity for thiol and amino groups of peptides, enzymes and nucleic acids and is extremely toxic to cells [28]. The present study showed that the MDA concentration in the liver and kidney was significantly higher in male mice exposed to the nanocomposite (Table 3). These results are in support of those from Huang et al. [22], who exposed mice to chlorides of various lanthanides, including Neodymium, and they observed a dose-dependent accumulation of RREs in hepatocytes and reported that catalase and SOD activities were decreased, while glutathione, glutathione peroxidase activity and malondialdehyde levels were elevated in hepatocytes. They concluded that oral administration of La, Ce and Nd leads to their accumulation in the nuclei and mitochondria of hepatocytes, resulting in oxidative stress.
5. Conclusions
In conclusion, we report that the two applied doses (10 and 20 mg/KgKg body weight) of the Neodymium Zirconate Zinc Sulfide nanocomposite significantly affect blood hemoglobin, serum cholesterol and triglyceride levels and biomarkers of oxidative stress in vital organs of albino mice of both sexes, but the effects were more pronounced in female mice and animals exposed to a lower dose of the nanocomposite.
Author Contributions
F.I. and A.K. designed and supervised the study and revised the manuscript. T.K., S.J., Q.F. and H.H. performed the animal house experiments and collected the samples, Z.U.R. and R.I. performed biochemical analysis and M.A. and A.K. conducted the antioxidant analysis in vital organs. M.B.S. performed the statistical analysis. T.K. and M.B.S. wrote the original manuscript and all the authors have reviewed and revised the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
No specific funding was available for this research.
Institutional Review Board Statement
All experimental protocols and animal handling procedures were approved by the Bioethics Committee of the Institute of Pure and Applied Biology in accordance with the guidelines of the Institutional Review Board (IRB), Bahauddin Zakariya University Multan Pakistan, via the approval number Biol/Ethics/2017-63.
Informed Consent Statement
Not applicable.
Data Availability Statement
All the data generated during this project are presented in the manuscript.
Acknowledgments
Authors are grateful to Laraib Nisar from the Institute of Chemical Sciences, Bahauddin Zakariya University Multan (Pakistan), for the synthesis of the nanocomposite.
Conflicts of Interest
The authors declare no conflict of interest.
References
- He, M.L.; Wehr, U.; Rambeck, W.A. Effect of low doses of dietary rare earth elements on growth performance of broilers. J. Anim. Physiol. Anim. Nutr. 2020, 94, 86–92. [Google Scholar] [CrossRef] [PubMed]
- Liang, Q.; Yin, H.; Li, J.; Zhang, L.; Hou, R.; Wang, S. Investigation of rare earth elements in urine and drinking water of children in mining area. Medicine 2018, 97, e12717. [Google Scholar] [CrossRef]
- Zhuang, M.; Zhao, J.; Li, S. Concentrations and health risk assessment of rare earth elements in vegetables from mining area in Shandong, China. Chemosphere 2017, 168, 578–582. [Google Scholar] [CrossRef] [PubMed]
- Zhang, D.Y.; Shen, X.Y.; Ruan, Q. Effects of subchronic samarium exposure on the histopathological structure and apoptosis regulation in mouse testis. Environ. Toxicol. Pharmacol. 2014, 37, 505–512. [Google Scholar] [CrossRef] [PubMed]
- Haque, N.; Hughes, A.; Lim, S.; Vernon, C. Rare earth elements, overview of mining, mineralogy, uses, sustainability and environmental impact. Resources 2014, 3, 614–635. [Google Scholar] [CrossRef] [Green Version]
- Kim, Y.; Lim, C.; Shin, S.; Kim, J. Twenty-Eight-Day Repeated Inhalation Toxicity Study of Nano-Sized Neodymium Oxide in Male Sprague-Dawley Rats. Toxicol. Res. 2017, 33, 239–253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Khosa, T.; Faiz, A.; Haider, A.; Ashiq, M.N.; Iqbal, F. Synthesis and characterization of newly synthesized Neodymium Zirconate Zinc Sulfide nano composite and its effect on selected aspects of albino mice behavior. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2020, 393, 717–725. [Google Scholar] [CrossRef]
- Akhtar, S.; Saba, S.; Rehman, S.; Hassan, A.; Samad, N.; Amir, M.; Iqbal, F. Microemulsion-based synthesis of strontium hexaferrite cobalt iron oxide nanoparticles and their biocompatibility in albino mice. J. Exp. Nanosci. 2018, 13, 199–210. [Google Scholar] [CrossRef] [Green Version]
- Salim, M.; Shahzeen, M.; Khan, M.N.; Tariq, R.; Muhammad, G.; Shabbir, G.; Nisar, L.; Ashiq, M.N.; Iqbal, F. Induction of selenium nanoparticles disturbs behavior, blood and serum biomarkers and oxidative stress markers from vital organs of male and female albino mice. J. Chem. Soc. Pak. 2022, 44, 59–68. [Google Scholar]
- Akram, I.N.; Akhtar, S.; Khadija, G.; Latif, M.; Noreen, A.; Mobeen, M.; Sajjad, F.; Sardar, Z.; Iqbal, S.; Ashiq, M.N.; et al. Synthesis, characterization and biocompatibility of Lanthanum Titanate nanoparticles in albino mice in a sex specific manner. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2020, 393, 1089–1101. [Google Scholar] [CrossRef]
- Noureen, H.; Salim, M.; Nadeem, A.; Shafiq, S.; Yousuf, S.; Samad, N.; Ashiq, M.N.; Iqbal, F. Synthesis, characterization and biocompatibility of Holmium Zirconate/Zinc Sulphide nanocomposite in albino mice in a gender specific manner. J. Chem. Soc. Pak. 2021, 43, 46–56. [Google Scholar]
- Saleem, A.; Khadija, G.; Akhtar, Z.; Mumtaz, S.; Rafiq, M.; Rubab, M.; Iqbal, F. Short term exposure to Titanium, Aluminum and Niobium (Ti-6Al-4Nb) alloy powder can disturb the serum low-density lipoprotein concentrations and antioxidant profile in vital organs but not the behavior of male albino mice. Drug Chem. Toxicol. 2020, 43, 298–306. [Google Scholar] [CrossRef]
- Khadija, G.; Saleem, A.; Akhtar, Z.; Naqvi, Z.; Gull, M.; Masood, M.; Iqbal, F. Short term exposure to titanium, aluminum and vanadium (Ti 6Al 4V) alloy powder drastically affects behavior and antioxidant metabolites in vital organs of male albino mice. Toxicol. Rep. 2018, 5, 765–770. [Google Scholar] [CrossRef]
- Henríquez-Hernández, L.A.; Boada, L.D.; Carranza, C.; Pérez-Arellano, J.L.; González-Antuña, A.; Camacho, M.; Almeida-González, M.; Zumbado, M.; Luzardo, O.P. Blood levels of toxic metals and rare earth elements commonly found in e-waste may exert subtle effects on hemoglobin concentration in sub-Saharan immigrants. Environ. Int. 2015, 109, 20–28. [Google Scholar] [CrossRef]
- Pagano, G.; Guida, M.; Tommasi, F.; Oral, R. Health effects and toxicity mechanisms of rare earth elements—Knowledge gaps and research prospects. Ecotoxicol. Environ. Saf. 2015, 115, 40–48. [Google Scholar] [CrossRef]
- Simundi, C.M.; Drasler, B.; Sustar, V. Effect of engineered TiO2 and ZnO nanoparticles on erythrocytes, platelet-rich plasma and giant unilamelar phospholipid vesicles. BMC Vet. Res. 2013, 9, 7. [Google Scholar]
- Rodríguez, L.; Galván, G.; González-Unzaga, M.; Hernandez-Avila, M.; Pérez-Labra, J. Blood toxic metals and hemoglobin levels in Mexican children. Environ. Monit. Asses. 2017, 189, 179–184. [Google Scholar] [CrossRef]
- Adu, O.A.; Akinmuyisitana, I.W.; Gbore, F.A. Growth performance and blood profile of female rabbits fed dietary Cerium Oxide. J. Biol. Sci. 2003, 21, 69–75. [Google Scholar] [CrossRef] [Green Version]
- Cheng, J.; Cheng, Z.; Hu, R. Immune dysfunction and liver damage of mice following exposure to Lanthanoids. J. Environ. Toxicol. 2011, 29, 64–73. [Google Scholar] [CrossRef]
- Wang, T.C.; He, X.; Zhang, Z.Y.; Jia, G.; Wang, X. Effects on serum glucose and lipids in chronic exposure to lanthanum chloride in rat. Yu Fang Yi Xue Za Zhi 2006, 40, 419–421. [Google Scholar]
- Shin, S.H.; Lim, C.H.; Kim, Y.S.; Lee, Y.H.; Kim, S.H.; Kim, J.C. Twenty-eight-day repeated inhalation toxicity study of nano-sized lanthanum oxide in male sprague-dawley rats. Environ. Toxicol. 2016, 32, 1226–1240. [Google Scholar] [CrossRef]
- Huang, P.; Li, J.; Zhang, S.; Chen, C.; Han, Y.; Liu, N.; Xiao, Y.; Wang, H.; Zhang, M.; Yu, Q.; et al. Effects of lanthanum, cerium, and neodymium on the nuclei and mitochondria of hepatocytes, Accumulation and oxidative damage. Environ. Toxicol. Pharmacol. 2011, 3, 25–32. [Google Scholar] [CrossRef]
- Kawagoe, M.; Ishikawa, K.; Wang, S.C.; Yoshikawa, K.; Arany, S.; Zhou, X.P.; Wang, J.S.; Ueno, Y.; Koizumi, Y.; Kameda, T.; et al. Acute effects on the lung and the liver of oral administration of cerium chloride on adult neonatal and fetal mice. J. Trace Elem. Med. Biol. 2008, 22, 59–65. [Google Scholar] [CrossRef]
- Aftab, M.N.; Akram, I.N.; Khosa, T.; Zahra, S.Q.; Bashir, I.; Ashiq, M.N.; Iqbal, F. Oral supplementation of Lanthanum Zirconate nanoparticles moderately affected behavior but drastically disturbed leukocyte count, serum cholesterol levels and antioxidant parameters from vital organs of albino mice in a gender specific manner. Metabol. Brain Dis. 2018, 33, 1421–1429. [Google Scholar] [CrossRef]
- Zhao, H.; Cheng, Z.; Renping, H.; Chen, J.M.; Min, H.; Gong, Z. Oxidative Injury in the Brain of mice Caused by Lanthanid. Chemosphere 2011, 2, 174–189. [Google Scholar] [CrossRef]
- Zhao, H.; Hong, J.; Yu, X.; Zhao, X.; Hong, F.; Wang, L. Oxidative stress in the kidney injury of mice following exposure to lanthanides trichloride. Chemosphere 2013, 6, 878–885. [Google Scholar] [CrossRef]
- Matés, J.M.; Pérez-Gómez, C.; De Castro, I.N. Antioxidant enzymes and human diseases. J. Clin. Biochem. 1999, 32, 595–603. [Google Scholar] [CrossRef]
- Blokhina, O.; Virolainen, E.; Fagerstedt, K.V. Antioxidants, oxidative damage and oxygen deprivation stress, a review. J. Ann. Bot. 2003, 91, 179–194. [Google Scholar] [CrossRef]
Table 1.
Comparison of various studied parameters of blood count test between mice treated with Neodymium zirconate zinc sulfide nanocomposite, treated with low dose (10 mg/mL saline/kg body weight) and high dose (20 mg/mL saline/kg body weight) for 11 days with their respective untreated control groups. N = 8 for each treatment. Data are expressed as mean ± standard error of mean. p-value represents the results for two-sample t-test calculated for each studied parameter.
Table 1.
Comparison of various studied parameters of blood count test between mice treated with Neodymium zirconate zinc sulfide nanocomposite, treated with low dose (10 mg/mL saline/kg body weight) and high dose (20 mg/mL saline/kg body weight) for 11 days with their respective untreated control groups. N = 8 for each treatment. Data are expressed as mean ± standard error of mean. p-value represents the results for two-sample t-test calculated for each studied parameter.
| Experiment > | Low Dose (10 mg/mL solvent/kg body weight) | High Dose (20 mg/mL solvent/kg body weight) | ||||||
|---|---|---|---|---|---|---|---|---|
| Parameters | Saline Treated Male | Neodymium Zirconate Zinc Sulfide Treated Male | Saline Treated Female | Neodymium Zirconate Zinc Sulfide Treated Female | Saline Treated Male | Neodymium Zirconate Zinc Sulfide Treated Male | Saline Treated Female | Neodymium Zirconate Zinc Sulfide Treated Female |
| Red blood cells (×106 µL−1) | 4.99 ± 0.51 | 6.23 ± 0.62 | 6.31 ± 0.80 | 6.12 ± 0.59 | 4.99 ± 0.51 | 6.51 ± 1.1 | 6.31 ± 0.80 | 5.97 ± 0.71 |
| White blood cells (×103 µL−1) | 5.42 ± 1.6 | 4.25 ± 0.53 | 11.6 ± 3.9 | 13.4 ± 6.1 | 5.42 ± 1.6 | 10.75 ± 8 | 11.6 ± 3.9 | 8.85 ± 2.2 |
| Hemoglobin (gdL−1) | 10.97± 0.62 | 10.82 ± 0.31 | 10.61 ± 1.2 | 10.48 ± 0.83 | 10.97± 0.62 | 8.56 ± 0.9 * | 10.61 ± 1.2 | 9.81 ± 1.1 |
| Packed cell volume (%) | 26.5 ± 4.7 | 31.5 ± 3.9 | 37.1 ± 5.5 | 34.7 ± 4.7 | 26.5 ± 4.7 | 33.7 ± 9.5 | 37.1 ± 5.5 | 34.5 ± 4.7 |
| Mean corpuscular volume (fl) | 52.0 ± 5.1 | 49.60 ± 2.8 | 57.60 ± 2.4 | 55.19 ± 3.4 | 52.0 ± 5.1 | 48.7 ± 5 | 57.60 ± 2.4 | 56.54 ± 2.2 |
| Mean corpuscular hemoglobin (pg) | 17.18 ± 0.23 | 18.07 ± 1.3 | 14.57 ± 2.1 | 17.43 ± 0.65 | 17.18 ± 0.23 | 19.06 ± 2.3 | 14.57 ± 2.1 | 16.56 ± 0.56 |
| Mean corpuscular hemoglobin concentration (gdL−1) | 34.50 ± 3.7 | 37.15 ± 3.6 | 24.8 ± 3.7 | 32.86 ± 3.1 | 34.50 ± 3.7 | 41.1 ± 7.0 | 24.8 ± 3.7 | 29.57 ± 1.5 |
| Platelets (×103 µL−1) | 300 ± 72 | 388 ± 97 | 304 ± 41 | 335 ± 51 | 300 ± 72 | 360 ± 166 | 304 ± 41 | 347 ± 55 |
| Lymphocytes (×103 µL−1) | 4.08 ± 1.1 | 3.583 ± 0.40 | 9.05 ± 2.5 | 8.5 ± 3.8 | 4.08 ± 1.1 | 7.6 ± 4.6 | 9.05 ± 2.5 | 6.78 ± 1.8 |
| Monocytes (×103 µL−1) | 0.060 ± 0.024 | 0.050 ± 0.022 | 0.213 ± 0.072 | 0.263 ± 0.14 | 0.060 ± 0.024 | 0.280 ± 0.21 | 0.213 ± 0.072 | 0.163 ± 0.042 |
| Granulocytes (×103 µL−1) | 1.24 ± 0.52 | 0.633 ± 0.15 | 2.41 ± 0.79 | 3.77 ± 2.4 | 1.24 ± 0.52 | 4.30 ± 3.2 | 2.41 ± 0.79 | 1.93 ± 0.40 |
| Lymphocyte (%) | 78 ± 5.1 | 84.60 ± 2.2 | 78.71 ± 2.1 | 76.42 ± 3.5 | 78 ± 5.1 | 73 ± 6.2 | 78.71 ± 2.1 | 75.24 ± 2.2 |
| Monocytes (%) | 1.140 ± 0.25 | 1.150 ± 0.18 | 17.63 ± 0.15 | 1.613 ± 0.18 | 1.140 ± 0.25 | 1.720 ± 0.29 | 17.63 ± 0.15 | 1.837 ± 0.19 |
| Granulocytes (%) | 20.9 ± 4.9 | 14.25 ± 2.1 | 19.52 ± 2.0 | 21.96 ± 3.3 | 20.9 ± 4.9 | 25.2 ± 6 | 19.52 ± 2.0 | 23.41 ± 2.3 |
| Red cell distribution width (%) | 24.90 ± 1.7 | 25.53 ± 2.6 | 12.25 ± 0.92 | 21.0 ± 0.74 | 24.90 ± 1.7 | 25.38 ± 3.5 | 12.25 ± 0.92 | 21.73 ± 1.2 |
| Red cell distribution width -SD | 43.98 ± 4.4 | 40.85 ± 3.0 | 47.1 ± 3.8 | 44.3 ± 3.9 | 43.98 ± 4.4 | 38.12 ± 3.8 | 47.1 ± 3.8 | 45.0 ± 1.8 |
| Platelet distribution width (%) | 13.98 ± 1.7 | 15.92 ± 1.9 | 13.6 ± 1.4 | 13.40 ± 1.1 | 13.98 ± 1.7 | 13.98 ± 0.75 | 13.6 ± 1.4 | 13.64 ± 1.4 |
| Platelet crit | 0.223 ± 0.047 | 0.275 ± 0.061 | 0.215 ± 0.03 | 0.237 ± 0.035 | 0.223 ± 0.047 | 0.249 ± 0.041 | 0.215 ± 0.03 | 0.249 ± 0.041 |
| Mean platelet volume (fl) | 7.28 ± 0.65 | 7.250 ± 0.39 | 7.087 ± 0.21 | 7.20 ± 0.42 | 7.28 ± 0.65 | 7.320 ± 0.44 | 7.087 ± 0.21 | 0.7287 ± 0.35 |
p > 0.05 = Non-significant; p < 0.05 = Least significant (*).
Table 2.
Comparison of various studied parameters of serum biochemical analysis between mice with Neodymium zirconate zinc sulfide nanocomposite treated with low dose (10 mg/mL saline/kg body weight) and high dose (20 mg/mL saline /kg body weight) for 11 days with their respective untreated control groups. N = 8 for each treatment. Data are expressed as the mean ± standard error of the mean. p-values represent the results for two-sample t-test calculated for each studied parameter.
Table 2.
Comparison of various studied parameters of serum biochemical analysis between mice with Neodymium zirconate zinc sulfide nanocomposite treated with low dose (10 mg/mL saline/kg body weight) and high dose (20 mg/mL saline /kg body weight) for 11 days with their respective untreated control groups. N = 8 for each treatment. Data are expressed as the mean ± standard error of the mean. p-values represent the results for two-sample t-test calculated for each studied parameter.
| Experiment > | Low Dose (10 mg/mL solvent/kg body weight) | High Dose (20 mg/mL solvent/kg body weight) | ||||||
|---|---|---|---|---|---|---|---|---|
| Parameters | Saline Treated Male | Neodymium Zirconate Zinc Sulfide Treated Male | Saline Treated Female | Neodymium Zirconate Zinc Sulfide Treated Female | Saline Treated Male | Neodymium Zirconate Zinc Sulfide Treated Male | Saline Treated Female | Neodymium Zirconate Zinc Sulfide Treated Female |
| Cholesterol mg/dL | 156 ± 7.8 | 167.2 ± 7.5 | 154.2 ± 17 | 190.0 ± 4.7 | 156 ± 7.8 | 171.4 ± 5.2 | 154.2 ± 17 | 194.2 ± 1.7 * |
| Triglycerides mgdL−1 | 150.3 ± 24 | 162.0 ± 17 | 168.6 ± 7.5 | 219.2 ± 18 * | 150.3 ± 24 | 151.9 ± 14 | 168.6 ± 7.5 | 222.1 ± 19 * |
| Creatinine mgdL−1 | 33.7 ± 28 | 16.1 ± 5.6 | 4.28 ± 2.4 | 7.10 ± 2.3 | 33.7 ± 28 | 14.2 ± 4.3 | 4.28 ± 2.4 | 10.8 ± 6.1 |
| High density lipoprotein m | 50.5 ± 5.4 | 49.6 ± 6.7 | 45.79 ± 3.0 | 45.60 ± 1.8 | 50.5 ± 5.4 | 61.6 ± 7.9 | 45.79 ± 3.0 | 50.3 ± 1.6 |
| Low density lipoprotein mgdL−1 | 78.6± 11 | 88.7 ± 6.2 | 82.6 ± 13 | 102.1 ± 8.8 | 78.6± 11 | 78.1 ± 9.4 | 82.6 ± 13 | 91.35 ± 4.2 |
p > 0.05 = Non-significant; p < 0.05 = Least significant (*).
Table 3.
Comparison of various studied antioxidant parameters between male/female albino mice supplemented orally for 11 days either with saline solution or 10 mg/mL solvent/KgKg body weight of Neodymium zirconate zinc sulfide nanocomposite. All values are expressed as mean ± slandered error of mean. p-value presents the results for the 2-sample t-test calculated for each parameter.
Table 3.
Comparison of various studied antioxidant parameters between male/female albino mice supplemented orally for 11 days either with saline solution or 10 mg/mL solvent/KgKg body weight of Neodymium zirconate zinc sulfide nanocomposite. All values are expressed as mean ± slandered error of mean. p-value presents the results for the 2-sample t-test calculated for each parameter.
| Male | Parameter | Brain | Heart | Liver | Kidney | Lungs | ||||||||||
| Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | ||
| Super oxide dismutase Unit/g | 0.395± 0.22 | 3.32 ± 2.6 | 0.3 | 0.593 ± 0.21 | 0.742 ± 0.21 | 0.6 | 3.50 ± 1.5 | 9.01 ± 3.3 | 0.2 | 1.073 ± 0.32 | 2.75 ± 1.3 | 0.2 | 0.199 ± 0.080 | 2.66 ± 1.5 | 0.1 | |
| Malonaldehyde Pico mol/g | 160.3± 25 | 177.3 ± 19 | 0.6 | 464 ± 115 | 518 ± 85 | 0.7 | 169.2 ± 4.6 | 180.7 ± 2.8 | 0.05 * | 375 ± 108 | 704 ± 81 | 0.03 * | 366 ± 52 | 408 ± 71 | 0.6 | |
| Catalase mg/dL | 30.7 ± 0.21 | 30.5 ± 0.29 | 0.6 | 29.83 ± 1.3 | 30.47 ± 2.2 | 0.8 | 7.33 ± 1.5 | 13.0 ± 3.9 | 0.2 | 26.19 ± 2.0 | 29.15 ± 1.8 | 0.2 | 29.7 ± 3.8 | 34.18 ± 3.3 | 0.3 | |
| Female | Parameter | Brain | Heart | Liver | Kidney | Lungs | ||||||||||
| Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | ||
| Super oxide dismutase Unit/g | 1.28 ± 0.74 | 2.49 ± 1.9 | 0.6 | 1.12 ± 47 | 0.865 ± 0.62 | 0.05 * | 0.46 ± 0.18 | 4.58 ± 3 | 0.3 | 1.22 ± 0.40 | 0.806 ± 0.70 | 0.2 | 0.567 ± 0.096 | 0.768 ± 0.83 | 0.3 | |
| Malonaldehyde Pico mol/g | 138.1 ± 13 | 170.5 ± 5.4 | 0.07 | 103 ± 14 | 59.0 ± 22 | 0.1 | 174.6 ± 5.3 | 168 ± 2.7 | 0.3 | 121 ± 18 | 20 ± 81.2 | 0.1 | 60.6 ± 19 | 90.5 ± 25 | 0.3 | |
| Catalase mg/dL | 31.8 ± 0.4 | 31.6 ± 0.13 | 0.9 | 32.08 ± 1.3 | 27.6 ± 1.9 | 0.07 | 8.08 ± 0.9 | 10.04 ± 1.8 | 0.4 | 31.64 ± 1.9 | 31.86 ± 3.8 | 0.9 | 29.47 ± 2.7 | 28 ± 1.7 | 0.7 | |
p > 0.05 = Non-significant; p < 0.05 = Least significant (*).
Table 4.
Comparison of various studied antioxidant parameters between male/female albino mice supplemented orally for 11 days either with saline solution or 20 mg/mL saline/KgKg body weight of Neodymium zirconate zinc sulfide nanocomposite All values are expressed as mean ± slandered error of mean. p-values present the results for the 2 sample t-test calculated for each parameter.
Table 4.
Comparison of various studied antioxidant parameters between male/female albino mice supplemented orally for 11 days either with saline solution or 20 mg/mL saline/KgKg body weight of Neodymium zirconate zinc sulfide nanocomposite All values are expressed as mean ± slandered error of mean. p-values present the results for the 2 sample t-test calculated for each parameter.
| Male | Parameter | Brain | Heart | Liver | Kidney | Lungs | ||||||||||
| Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | ||
| Super oxide dismutase Unit/g | 0.395 ± 0.22 | 9.39 ± 3.0 | 0.05 * | 0.593 ± 0.21 | 2.11 ± 1.5 | 0.3 | 3.50 ± 1.5 | 5.78 ± 2.2 | 0.4 | 1.073 ± 0.32 | 3.23 ± 1.2 | 0.1 | 0.199 ± 0.080 | 3.82 ± 2.1 | 0.1 | |
| Malonaldehyde Pico mol/ g | 160.3 ± 25 | 193.8 ± 17 | 0.3 | 464 ± 115 | 639 ± 69 | 0.2 | 169.2 ± 4.6 | 170.43 ± 3.3 | 0.8 | 3.75 ± 108 | 522 ± 86 | 0.3 | 366 ± 52 | 403 ± 43 | 0.5 | |
| Catalase mg/dL | 30.7 ± 0.21 | 31.0 ± 0.53 | 0.8 | 29.83 ± 1.3 | 29.3 ± 4.9 | 0.9 | 7.33 ± 1.5 | 5.24 ± 0.6 | 0.2 | 26.19 ± 2.0 | 36.6 ± 3.8 | 0.03 * | 29.7 ± 3.8 | 31.9 ± 4.4 | 0.7 | |
| Female | Parameter | Brain | Heart | Liver | Kidney | Lungs | ||||||||||
| Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | Control | Treated | p Value | ||
| Super oxide dismutase Unit/g | 1.28 ± 0.74 | 1.83 ± 1.7 | 0.8 | 1.12 ± 47 | 02.41 ± 1.4 | 0.3 | 0.46 ± 0.18 | 0.61 ± 0.41 | 0.7 | 1.22 ± 0.40 | 248.6 ± 11 | 0.6 | 0.567 ± 0.096 | 21.4 ± 5.2 | 0.3 | |
| Malonaldehyde Pico mol/ g | 138.1 ± 13 | 145.4 ± 16 | 0.7 | 103 ± 14 | 65.7 ± 11 | 0.05 * | 174.6 ± 5.3 | 174.3 ± 3.0 | 0.1 | 121 ± 18 | 114 ± 1.08 | 0.03 * | 60.6 ± 19 | 58.2 ± 21 | 0.3 | |
| Catalase mg/dL | 31.8 ± 0.4 | 31.6 ± 0.24 | 0.8 | 32.08 ± 1.3 | 24.35 ± 2.5 | 0.1 | 8.08 ± 0.9 | 14.54 ± 3.1 | 0.07 | 31.64 ± 1.9 | 19.5 ± 3.7 | 0.01 ** | 29.47 ± 2.7 | 11.3 ± 4.0 | 0.7 | |
p > 0.05 = Non significant; p < 0.05 = Least significant (*); p < 0.01 = Significant (**).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Khosa, T.; Ben Said, M.; Rehman, Z.U.; Ali, M.; Jamil, S.; Fatima, Q.; Hussain, H.; Iqbal, R.; Khan, A.; Iqbal, F. Varying Doses of Rare-Earth-Metal-Based Neodymium Zirconate Zinc Sulfide Nanocomposite Disrupt Blood and Serum Parameters, as well as Markers of Oxidative Stress in the Selected Organs of Albino Mice. Genes 2022, 13, 2262. https://doi.org/10.3390/genes13122262
AMA Style
Khosa T, Ben Said M, Rehman ZU, Ali M, Jamil S, Fatima Q, Hussain H, Iqbal R, Khan A, Iqbal F. Varying Doses of Rare-Earth-Metal-Based Neodymium Zirconate Zinc Sulfide Nanocomposite Disrupt Blood and Serum Parameters, as well as Markers of Oxidative Stress in the Selected Organs of Albino Mice. Genes. 2022; 13(12):2262. https://doi.org/10.3390/genes13122262
Chicago/Turabian StyleKhosa, Tafheem, Mourad Ben Said, Zia Ur Rehman, Muhammad Ali, Sania Jamil, Qandeel Fatima, Hafsa Hussain, Rehana Iqbal, Adil Khan, and Furhan Iqbal. 2022. "Varying Doses of Rare-Earth-Metal-Based Neodymium Zirconate Zinc Sulfide Nanocomposite Disrupt Blood and Serum Parameters, as well as Markers of Oxidative Stress in the Selected Organs of Albino Mice" Genes 13, no. 12: 2262. https://doi.org/10.3390/genes13122262
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
